Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HC009 Oral Solution for Diminished Ovarian Reserve (Kidney Deficiency and Liver Stagnation Pattern)
CTR20254996Phase 2Active
- Sponsor
- Houcheng Pharma
- Start
- Dec 2025
- Countries
- 1
01
Overview
A Phase 2 trial of HC009 in Diminished Ovarian Reserve (DOR), sponsored by Houcheng Pharma. Started Dec 2025; status: active.
02
Drugs
HC009
03
Conditions
Diminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on CTR20254996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254996.